XP Analyst Ratings
XP Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/01/2023 | 28.03% | UBS | $28 → $33 | Maintains | Buy |
| 08/23/2023 | 4.75% | JP Morgan | $18.5 → $27 | Maintains | Neutral |
| 08/21/2023 | 16.39% | Citigroup | $20 → $30 | Maintains | Buy |
| 07/20/2023 | 0.87% | Credit Suisse | $15 → $26 | Upgrades | Underperform → Neutral |
| 07/10/2023 | 12.51% | Goldman Sachs | $22 → $29 | Maintains | Buy |
| 06/22/2023 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 05/18/2023 | -34.04% | Banco Bradesco BBI S.A | $25 → $17 | Downgrades | Outperform → Neutral |
| 05/16/2023 | -14.65% | Goldman Sachs | $20 → $22 | Maintains | Buy |
| 03/31/2023 | -18.53% | UBS | $28 → $21 | Maintains | Buy |
| 03/02/2023 | -22.41% | Goldman Sachs | $30 → $20 | Maintains | Buy |
| 02/28/2023 | -22.41% | HSBC | $26 → $20 | Maintains | Buy |
| 02/27/2023 | -26.29% | Citigroup | $24 → $19 | Maintains | Buy |
| 02/17/2023 | -41.8% | Credit Suisse | $27 → $15 | Downgrades | Neutral → Underperform |
| 01/18/2023 | 16.39% | Goldman Sachs | $35 → $30 | Maintains | Buy |
| 11/28/2022 | 35.79% | Goldman Sachs | $40 → $35 | Maintains | Buy |
| 10/13/2022 | 55.19% | Goldman Sachs | $46 → $40 | Maintains | Buy |
| 08/16/2022 | 55.19% | Goldman Sachs | $46 → $40 | Maintains | Buy |
| 08/11/2022 | -10.77% | JP Morgan | → $23 | Downgrades | Overweight → Neutral |
| 06/07/2022 | 20.27% | UBS | $37 → $31 | Upgrades | Neutral → Buy |
| 10/15/2021 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 05/25/2021 | 66.83% | Credit Suisse | $40 → $43 | Upgrades | Underperform → Neutral |
| 04/29/2021 | 78.47% | HSBC | → $46 | Initiates Coverage On | → Buy |
| 10/16/2020 | 93.99% | B of A Securities | $20 → $50 | Upgrades | Underperform → Neutral |
| 06/24/2020 | 55.19% | Credit Suisse | $22 → $40 | Downgrades | Neutral → Underperform |
| 06/01/2020 | 8.63% | JP Morgan | $33 → $28 | Downgrades | Overweight → Neutral |
| 04/27/2020 | -22.41% | B of A Securities | $43 → $20 | Downgrades | Neutral → Underperform |
| 04/03/2020 | 0.87% | Citigroup | → $26 | Upgrades | Neutral → Buy |
| 01/06/2020 | 74.59% | Morgan Stanley | → $45 | Initiates Coverage On | → Overweight |
| 01/06/2020 | 70.71% | JP Morgan | → $44 | Initiates Coverage On | → Neutral |
| 01/06/2020 | 55.19% | Goldman Sachs | → $40 | Initiates Coverage On | → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/01/2023 | 28.03% | 瑞銀集團 | $28→$33 | 維護 | 買 |
| 2023/08/23 | 4.75% | 摩根大通 | $18.5→$27 | 維護 | 中性 |
| 2023年08月21日 | 16.39% | 花旗集團 | $20→$30 | 維護 | 買 |
| 07/20/2023 | 0.87% | 瑞士信貸 | $15→$26 | 升級 | 表現不佳的→中性 |
| 07/10/2023 | 12.51% | 高盛 | $22→$29 | 維護 | 買 |
| 2023/06/22 | - | B of A證券 | 升級 | 中性→購買 | |
| 2023年05月18日 | -34.04% | Banco Bradesco BBI SA | $25→$17 | 評級下調 | 跑贏→中性 |
| 2023年05月16日 | -14.65% | 高盛 | $20→$22 | 維護 | 買 |
| 03/31/2023 | -18.53% | 瑞銀集團 | $28→$21 | 維護 | 買 |
| 03/02/2023 | -22.41% | 高盛 | $30→$20 | 維護 | 買 |
| 02/28/2023 | -22.41% | 匯豐銀行 | $26→$20 | 維護 | 買 |
| 02/27/2023 | -26.29% | 花旗集團 | $24→$19 | 維護 | 買 |
| 02/17/2023 | -41.8% | 瑞士信貸 | $27→$15 | 評級下調 | 中性→表現不佳 |
| 01/18/2023 | 16.39% | 高盛 | $35→$30 | 維護 | 買 |
| 2022年11月28日 | 35.79% | 高盛 | $40→$35 | 維護 | 買 |
| 10/13/2022 | 55.19% | 高盛 | $46→$40 | 維護 | 買 |
| 08/16/2022 | 55.19% | 高盛 | $46→$40 | 維護 | 買 |
| 2022年08月11日 | -10.77% | 摩根大通 | →$23 | 評級下調 | 超重→中性 |
| 06/07/2022 | 20.27% | 瑞銀集團 | $37→$31 | 升級 | 中性→購買 |
| 2021年10月15日 | - | 摩根大通 | 升級 | 中性→超重 | |
| 2021/05/25 | 66.83% | 瑞士信貸 | $40→$43 | 升級 | 表現不佳的→中性 |
| 04/29/2021 | 78.47% | 匯豐銀行 | →$46 | 開始承保 | →購買 |
| 10/16/2020 | 93.99% | B of A證券 | $20→$50 | 升級 | 表現不佳的→中性 |
| 06/24/2020 | 55.19% | 瑞士信貸 | $22→$40 | 評級下調 | 中性→表現不佳 |
| 06/01/2020 | 8.63% | 摩根大通 | $33→$28 | 評級下調 | 超重→中性 |
| 04/27/2020 | -22.41% | B of A證券 | $43→$20 | 評級下調 | 中性→表現不佳 |
| 04/03/2020 | 0.87% | 花旗集團 | →$26 | 升級 | 中性→購買 |
| 01/06/2020 | 74.59% | 摩根士丹利 | →$45 | 開始承保 | →超重 |
| 01/06/2020 | 70.71% | 摩根大通 | →$44 | 開始承保 | →中性 |
| 01/06/2020 | 55.19% | 高盛 | →$40 | 開始承保 | →中性 |
What is the target price for XP (XP)?
XP(XP)的目標價格是多少？
The latest price target for XP (NASDAQ: XP) was reported by UBS on September 1, 2023. The analyst firm set a price target for $33.00 expecting XP to rise to within 12 months (a possible 28.03% upside). 16 analyst firms have reported ratings in the last year.
瑞銀於2023年9月1日報道了XP(納斯達克代碼：XP)的最新目標價。這家分析公司將目標價定為33.00美元，預計XP將在12個月內上漲(可能上漲28.03%)。過去一年，有16家分析公司公佈了評級。
What is the most recent analyst rating for XP (XP)?
XP(XP)的最新分析師評級是什麼？
The latest analyst rating for XP (NASDAQ: XP) was provided by UBS, and XP maintained their buy rating.
分析師對XP(納斯達克：XP)的最新評級由瑞銀提供，XP維持買入評級。
When is the next analyst rating going to be posted or updated for XP (XP)?
XP(XP)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of XP, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for XP was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與XP的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。XP的上一次評級是在2023年9月1日提交的，所以你應該預計下一次評級將在2024年9月1日左右提供。
Is the Analyst Rating XP (XP) correct?
分析師評級XP(XP)正確嗎？
While ratings are subjective and will change, the latest XP (XP) rating was a maintained with a price target of $28.00 to $33.00. The current price XP (XP) is trading at is $25.78, which is out of the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的XP(XP)評級保持不變，目標價在28.00美元到33.00美元之間。目前XP的交易價格為25.78美元，超出了分析師的預測範圍。